Correlation Between Ardelyx and Hepion Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Ardelyx and Hepion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ardelyx and Hepion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ardelyx and Hepion Pharmaceuticals, you can compare the effects of market volatilities on Ardelyx and Hepion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ardelyx with a short position of Hepion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ardelyx and Hepion Pharmaceuticals.

Diversification Opportunities for Ardelyx and Hepion Pharmaceuticals

0.07

Correlation Coefficient

Ardelyx  Hepion Pharmaceuticals

Significant diversification

The 3 months correlation between Ardelyx and Hepion is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Ardelyx and Hepion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hepion Pharmaceuticals and Ardelyx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ardelyx are associated (or correlated) with Hepion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hepion Pharmaceuticals has no effect on the direction of Ardelyx i.e., Ardelyx and Hepion Pharmaceuticals go up and down completely randomly.

Pair Corralation between Ardelyx and Hepion Pharmaceuticals

Given the investment horizon of 90 days Ardelyx is expected to under-perform the Hepion Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Ardelyx is 1.18 times less risky than Hepion Pharmaceuticals. The stock trades about -0.04 of its potential returns per unit of risk. The Hepion Pharmaceuticals is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  68.00  in Hepion Pharmaceuticals on September 14, 2024 and sell it today you would lose (6.00) from holding Hepion Pharmaceuticals or give up 8.82% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Ardelyx  vs.  Hepion Pharmaceuticals

Ardelyx

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Ardelyx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest inconsistent performance, the Stock's fundamental indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Hepion Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Hepion Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Hepion Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Ardelyx and Hepion Pharmaceuticals

The main advantage of trading using opposite Ardelyx and Hepion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ardelyx position performs unexpectedly, Hepion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hepion Pharmaceuticals will offset losses from the drop in Hepion Pharmaceuticals' long position.

The idea behind Ardelyx and Hepion Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.